System.Func`1[System.String]

How McKesson Uses Predictive Analytics to Help Health Systems Identify Drug Profitability

The UA tool provides insights that allow customers to understand the impact of their formulary and purchasing decisions.

By McKesson Health Systems Editorial Team

Date

March 07, 2023

<span>Business Team Meeting and discussing to audit financial planning sales</span>

Read time: 4 minutes

By: Nicole Mayo

Understanding Predictive Analytics

The increased adoption of electronic health records has improved the way in which patient information is collected and stored. The resulting volume of generated patient data has prompted healthcare entities to invest in tools which analyze patient data and provide actionable insights.

According to a BBC Research report1, hospitals spent an estimated $6.2 billion on analytics resources in 2017. This number was expected to soar to $14.9 billion by close of 2022.

Hospitals have begun identifying links between disease states, social determinants of health, and drug therapies and missed appointments, utilization of medical services, and readmission rates. Armed with these insights, they are addressing these gaps by incorporating additional support and resources where needed most.

By targeting specific outcomes and examining historic data, predictive analytics allows stakeholders to identify patterns and commonalities across data points. Stakeholders can then proactively devise strategies to minimize the recurrence of those future events.

Health system pharmacies deploy similar predictive analytics methods to alter drug procurement patterns, render formulary decisions, and establish pharmacy budgets.

Predictive Analytics Moving Forward

Health systems are now leveraging all available insights to make better informed decisions. Algorithms and predictive analytics allow for more proactive decision-making and drive sustainability strategies. By examining historic trends and fluctuations in drug utilization, procurement teams can establish analytically sound strategies to avoid over- or under-purchasing drugs. In addition, health care entities will be able to see the value in understanding how drugs are being reimbursed and why this is important when making formulary decisions and establishing best practices.

With the increase of new drug therapies and biosimilar agents, health system pharmacies are shifting their cost containment strategies and investing more resources into tools that will streamline the decision-making process.

How McKesson Uses Predictive Analytics to Help Customers

Data insights within the Utilization Analytics (UA) tool allow health system customers to fully understand the impact of their formulary and purchasing decisions while equipping them to have larger conversations with multidisciplinary teams outside of pharmacy.

Through the incorporation of assumptions within the analysis, UA customers can examine scenarios on a more granular level. Understanding the implications of payer distribution, site of care nuances, and fluctuating reimbursement rates allows UA users to conduct predictive profitability analysis and identify drug profit margins.

Click to learn how McKesson’s Utilization Analytics can help your health system achieve more while enhancing visibility into the financial performance of your health system pharmacy.

Expect more from your distributor. Achieve more with McKesson.

 

1BCC Research LLC. (Nov 2017). Healthcare analytics: Technologies and global markets.

Subscribe Now
To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.
Subscribe

Related Stories

Two people in a warehouse with overlaid text: "Advanced Therapies Require End-to-End Visibility and Communication in the Supply Chain."

Hear part two of LogiPharma’s interview with McKesson Health Systems President Ammie McAsey.

Read More

A person in a white lab coat smiles, holding a clipboard in a pharmacy with shelves of medication behind.

On Women Pharmacist Day, we recognize the unique perspectives and contributions of these critical healthcare professionals.

Read More

Meeting New Demands in the Supply Chain Through Collaboration on a blurred network background.

McKesson Health Systems President Ammie McAsey joins a keynote panel to discuss the growing importance of collaboration across the healthcare ecosystem.

Read More

Person holding a tablet with glowing digital icons and a world map overlay.

McKesson Health Systems President Ammie McAsey contributes expert insights on how we’re enabling pharmacy to do more for the advancement of patient health.

Read More

A hand holds a magnifying glass with a blue medical cross, focusing on a search bar in a blurred office or hospital background.

An interactive experience highlighting key insights for success across 8 domains of specialty pharmacy.

Read More

Hands of medical professionals discussing charts and graphs with a calculator on a table.

Does your health system have a dedicated concierge service monitoring contract pricing accuracy now and in the future?

Read More

Person in a white coat standing behind shelves filled with various containers and items.

This American Pharmacists Month, we honor the people, patients, and partnerships that define the extraordinary impact of health system pharmacy in the community and beyond.

Read More

A person in a white lab coat stands in a bright room holding a tablet, with shelves and cabinets in the background.

The most downloaded content by health system pharmacy leaders in September 2025.

Read More

Two people in white lab coats work in a pharmacy with shelves of medications behind them. One writes on a clipboard, while the other examines a bottle.

One of our Specialty Pharmacy Enablement (SPE) experts outlines her three-pronged approach for success and suggests the addition of a critical fourth.

Read More

Text asks if health systems can change perceptions of generic drugs, with two medicine bottles and a blurred pharmacy background.

Consider the four “P’s” of generic drugs that support the case for wider adoption of generics in the health system and beyond.

Read More